The insight and the risk of psychiatric re-hospitalization in patients suffering from schizophrenia
DOI:
https://doi.org/10.12923/j.2081-3910/13.4/a.12Keywords:
schizophrenia, insight, re-hospitalizationAbstract
Despite significant advances in the treatment and rehabilitation of schizophrenic patients, high relapse rates in the course of this disease are still observed, frequently resulting in psychiatric hospitalization. Insight into illness is an important component of the presentation and its level may play an important role in assessing risk of hospitalization in the course of schizophrenia.
This paper reviews the literature in order to determine relationships between insight into illness and the risk of hospital readmission among schizophrenic patients. Due to the complexity of the phenomenon of insight, study findings in this area are not always consistent. Lower insight may be associated with poorer compliance, more fulminant course of illness and more frequent occurrence of aggressive behavior in patients with schizophrenia, which consequently may predispose to more frequent psychiatric hospitalizations.
On the other hand, lower insight may also contribute to lower severity of depressive symptoms and suicidal tendencies, which in turn may reduce the risk of hospitalization. The studies on relationships between the level of insight into illness in schizophrenia and the risk of hospitalization have to date yielded no conclusive results and should be continued.
References
1. Carr VJ., Neil AL., Halpin SA., Holmes S., Levin TJ. : Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study. Australia and New Zeland Journal of Psychiatry. 2003, 37:31-40. https://doi.org/10.1046/j.1440-1614.2003.01092.x
2. Hendryx MS., Russo JE., Stegner B., Dyck DG., Ries RK., Roy-Byrne P.: Predicting rehospitalization and outpatient services from administration and clinical databases. Journal of Behavioral and Health Services Research. 2003; 30:342-351. https://doi.org/10.1097/00075484-200307000-00007
3. Olfson M., Mechanic D., Boyer C., Hansell S., Walkup J., Weiden PJ.: Assessing clinical predictions of early rehospitalization in schizophrenia. Journal of Nervous and Mental Disease. 1999; 187:721-729. https://doi.org/10.1097/00005053-199912000-00003
4. Valenstein M., Ganoczy D., McCarthy JF., Myra Kim H., Lee TA., Blow FC.: Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. Journalof Clinical Psychiatry. 2006; 67:1542-1550. https://doi.org/10.4088/jcp.v67n1008
5. Doering S., Muller E., Kopcke W., Pietzcker A., Gaebel W., Linden M., Muller P., Muller; Spahn F., Tegeler J., Schussler G. : Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophrenia Bulletin. 1998; 24:87-98. https://doi.org/10.1093/oxfordjournals.schbul.a033316
6. Schennach R., Obermeier M., Meyer S., Jäger M., Schmauss M., Laux G., Pfeiffer H., Naber D., Schmidt L., Gaebel W., Klosterkötter J., Heuser I., Maier W., Lemke M., Rüther E., Klingberg S., Gastpar M., Seemüller F., Möller H., Riedel M.: Predictors of Relapse in the Year After Hospital Discharge Among Patients With Schizophrenia. Psychiatric Services. 2012; 63:87-90. https://doi.org/10.1176/appi.ps.201100084
7. Feigon S., Hays J. R.: Prediction of readmission of psychiatric inpatients. Psychol. Rep. 2003; 93: 816-818. https://doi.org/10.2466/pr0.2003.93.3.816
8. Grossman L.S., Harrow M., Rosen C. Faull R: Sex differences in recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr. Serv. 2006;57:844-850. https://doi.org/10.1176/ps.2006.57.6.844
9. Mahendran R., Mythily, Chong S.A., Chan YH.: Brief communication factors affecting rehospitalization in psychiatric patients in Singapore. Int. J. Soc. Psychiatry. 2005; 51:101-105. https://doi.org/10.1177/0020764005053264
10. Lincoln TM., Lullmann E., Rief W. Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review Schizophrenia Bulletin. 2007; 33 (6):1324-1342. https://doi.org/10.1093/schbul/sbm002
11. Amador XF., Gorman JM. Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am. 1998; 21: 27-42. https://doi.org/10.1016/s0193-953x(05)70359-2
12. Davidhizar RE, Austin JK, McBride AB. Attitudes of patients with schizophrenia toward taking medication. Res Nurs Health. 1986; 9: 139-146. https://doi.org/10.1002/nur.4770090209
13. Markova IS, Berrios GE. Insight in clinical psychiatry. J Nerv Ment Dis. 1995; 183: 743-751.
14. David AS. Insight and psychosis. Br J Psychiatry. 1990; 156:798-808.
15. Cooke MA., Fannon D., Kuipers E., Peters E., Williams SC., Kumari V. Neurological basis of poor insight in psychosis: a voxel-based MRI study. Schizophr Res. 2008;103:40-51. https://doi.org/10.1016/j.schres.2008.04.022
16. Aleman A., Agrawal N., Morgan KD., David AS. Insight in psychosis and neuropsychological function: meta-analysis. Br J Psychiatry. 2006;189:204-212. https://doi.org/10.1192/bjp.189.3.204
17. Parellada M., Fraguas D., Bombin I., Otero S., Castro-Fornieles J., Baeza I., Gonzales-Pinto A., Graell M., Soutullo C., Paya B., Arango C.. Insight correlates in child-and adolescent-onset first episodes of psychosis: results from the CAFEPS study. Psychol Med. 2009;39:1433-1445. https://doi.org/10.1017/s0033291708004868
18. Shad MU., Tamminga CA., Cullum M., Haas GL., Keshavan MS.. Insight and frontal cortical function in schizophrenia: a review. Schizophr Res. 2006;86:54-70. https://doi.org/10.1016/j.schres.2006.06.006
19. World Health Organization. Report of the International Pilot Study of Schizophrenia. Geneva: World Health Organization Press; 1973.
20. Wilson WH., Ban TA., Guy W. Flexible system criteria in chronic schizophrenia. Compr Psychiatry. 1986;27(3):259-65.
21. Carpenter WT, Strauss JS, Bartko JJ. Flexible system for the diagnosis of schizophrenia: report from the WHO International Pilot Study of Schizophrenia. Science. 1973;182(118):1275-8. https://doi.org/10.1126/science.182.4118.1275
22. Amador XF., David AS.. Insight and Psychosis. New York: Oxford University Press; 1998.
23. Cuesta MJ., Peralta V. Lack of insight in schizophrenia. Schizophr Bull. 1994;20:359-366.
24. Lysaker PH., Bryson GJ., Lancaster RS., Evans JD., Bell MD. Insight in schizophrenia: associations with executive function and coping style. Schizophr Res. 2003;59:41-47. https://doi.org/10.1016/s0920-9964(01)00383-8
25. Martens WH. The role of self-complexity in reducing harmful insight among persons with schizophrenia. Theoretical and therapeutic implications. Am J Psychother. 2009;63: 53-68. https://doi.org/10.1176/appi.psychotherapy.2009.63.1.53
26. Laroi F., Fannemel M., Ronneberg U., Flekkoy K., Opjordsomoen S., Dullerud R., Haakonsen M.:. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res. 2000;100:49-58. https://doi.org/10.1016/s0925-4927(00)00063-9
27. McEvoy JP., Hartman M., Gottlieb D., Gottlieb D., Godwin S., Apperson LJ., Wilson W. Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull. 1996;22:635-641. https://doi.org/10.1093/schbul/22.4.635
28. Arango C., Adami H., Sherr JD., Thaker GK., Carpenter WT., Jr. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry. 1999;156: 1097-1099. https://doi.org/10.1176/ajp.156.7.1097
29. Gilleen J., Greenwood K., David A. Anosognosia in schizophrenia and other neuropsychiatric disorders: similarities and differences. In: Prigatano G, ed. Advances in the Study of Anosognosia. New York, NY: Oxford Psychiatric Press. 2010:255-290.
30. Lele MV., Joglekar AS. Poor insight in schizophrenia: neurocognitive basis. J Postgrad Med. 1998;44:50-55.
31. Osatuke K., Ciesla J., Kasckow JW., Zisook S., Mohamed S. Insight in schizophrenia: a review of etiological models and supporting research. Compr Psychiatry. 2008;49:70-77. https://doi.org/10.1016/j.comppsych.2007.08.001
32. Lysaker PH., Lancaster RS., Davis LW., Clements CA. Patterns of neurocognitive deficits and unawareness of illness in schizophrenia. J Nerv Ment Dis. 2003;191(1):3844. https://doi.org/10.1097/00005053-200301000-00007
33. McEvoy JP., Johnson J., Perkins D., Liberman JA., Hamer RM., Keefe RS., Tohen M., Glick ID., Sharma T. Insight in first episode psychosis. Psychol Med. 2006;36:1385-1393. https://doi.org/10.1017/s0033291706007793
34. Rossell SL., Coakes J., Shapleske J., Woodruff PWR., David AS. Insight: its relationship with cognitive function, brain Volume and symptoms in schizophrenia. Psychol Med. 2003;33:111-119. https://doi.org/10.1017/s0033291702006803
35. Drake RJ., Pickles A., Bentall RP., Kinderman P., Haddock G., Tarrier N., Lewis SW. The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med. 2004;34:285-292. https://doi.org/10.1017/s0033291703008821
36. Flashman LA., Roth RM. Neural correlates of unawareness of illness in psychosis. In: Amador XF, David AS. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. New York, NY: Oxford University Press. 2004:157-176. https://doi.org/10.1093/med/9780198525684.003.0008
37. Crumlish N., Whitty P., Kamali M., Clarke M., Browne S., McTique O., Lane A., Kinsella A., Larkin C., O’Callaghan E. Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder. Acta Psychiatr Scand. 2005;112:449-455. https://doi.org/10.1111/j.1600-0447.2005.00620.x
38. Docherty JP., Mahmoud R Grogg AL., Kozma C.: Antipsychotic maintenance in schizophrenia: partial compliance and clinical outcome. Schizophrenia Research. 60(1);281-283. https://doi.org/10.1016/s0920-9964(03)80455-3
39. McCombs JS., Nichol MB., Stimmel GL., Shi J., Smith RR.: Use patterns for antipsychotic medications in Medicaid patients with schizophrenia. Journal of Clinical Psychiatry. 60(suppl 19):5-11, 1999.
40. Ayuso-Gutierrez JL., del Rio Vega JM.: Factors influencing relapse in the long-term course of schizophrenia. Schizophrenia Research. 1997, 28:199-206. https://doi.org/10.1016/s0920-9964(97)00131-x
41. Marder SR.: Facilitating compliance with antipsychotic medication. Journal of Clinical Psychiatry. 1998, 59(suppl 3):21-25.
42. Caseiro O, Perez-Iglesias R, Mata I, Martinez-Garcia O, Pelayo-Teran J, Tabares-Seisdedos R, Ortiz-Garcia de la Foz V, Vazquez-Barquero J, Crespo-Facorro B: Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study. Journal of Psychiatric Research. 2012, 46 (8): 1099-1105. https://doi.org/10.1016/j.jpsychires.2012.05.001
43. Weiden PJ., Zygmunt A.: The road back: working with the severely mentally ill. Medication noncompliance in schizophrenia: I. assessment. Journal of Practical Psychiatry and Behavioral Health. 1997 March:106-110.
44. Almond S., Knapp M., Francois C., Toumi M., Brugha T. Relapse in schzophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry. 2004; 184: 346-351. https://doi.org/10.1192/bjp.184.4.346
45. Weiden PJ., Kozma C., Grogg A., Locklear J.: Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia. Psychiatric Services. http://ps.psychiatryonline.org August 2004; 55 (8) :886-891. https://doi.org/10.1176/appi.ps.55.8.886
46. Valenstein M., Copeland LA., Blow FC., McCarthy JF., Zeber JE., Gillon L., Bingham CR., Stavenger T.: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care. 2002, 40:630-639. https://doi.org/10.1097/00005650-200208000-00002
47. Gilmer TP., Dolder CR., Lacro JP., Folsom DP., Lindamer L., Garcia P., Jeste DV.: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry. 2004, 161:692-699. https://doi.org/10.1176/appi.ajp.161.4.692
48. Morrisette D., Cutler A.: Strategies for optimizing medication adherence in schizophrenia. CNS Spectrums. 2012; 17(1): 31-41. https://doi.org/10.1017/s1092852912000405
49. Yen C-F., Chen C-S., Ko C-H., Yeh ML., Yang SJ., Yen JY., Huang CF., Wu CC. Relationships between insight and medication adherence in outpatients with schizophrenia an bipolar disorder: a prospective study. Psychiatry Clin Neurosci. 2005;59:403-409. https://doi.org/10.1111/j.1440-1819.2005.01392.x
50. Macpherson R., Jerrom B., Hughes A. Drug refusal among schizophrenic patients treated in the community. J Ment Health. 1997;6:141-147. https://doi.org/10.1080/09638239718905
51. Coldham EL., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286-290. https://doi.org/10.1034/j.1600-0447.2002.02437.x
52. Donohoe G., Owens N., O’Donnell C., Burke T., Moore L., Tobin A., O’Callaghan E. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analyses. Eur Psychiatry. 2001;16:293-298. https://doi.org/10.1016/s0924-9338(01)00581-8
53. Watson PWP., Garety PA., Weinman J., Dunn G., Bebbington PE., Fowler D., Freeman D., Kuipers E. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions. Psychol Med. 2006;36:761-770. https://doi.org/10.1017/s0033291706007458
54. Cuffel BJ., Alford J., Fischer EP., Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis. 1996;184:653-659. https://doi.org/10.1097/00005053-199611000-00001
55. Higashi K., Medic G., Diez T., Granstom O., De Hert M., Littiewood K.: Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence - a systematic literature review. Therapeutic Advances in Psychopharmacology tpp.sagepub.com 2013. https://doi.org/10.1177/2045125312474019
56. Day JC., Bentall R., Roberts C., Randall F., Rogers A., Cattell D., Healy D., Rae P., Power C. Attitudes toward antipsychotic medication—the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry. 2005;62:717-724. https://doi.org/10.1001/archpsyc.62.7.717
57. Moore A., Sellwood W., Stirling J. Compliance and psychological reactance in schizophrenia. Br J Clin Psychol. 2000;39:287-295. https://doi.org/10.1348/014466500163293
58. Agarwal MR., Sharma VK., Kumar K., Lowe D. Noncompliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry. 1998;44:92-106. https://doi.org/10.1177/002076409804400202
59. Smith CM., Barzman D., Pristach CA. Effect of patient and family insight on compliance of schizophrenic patients. J Clin Pharmacol. 1997;37:147-154. https://doi.org/10.1002/j.1552-4604.1997.tb04773.x
60. Kamali M., Kelly L., Gervin M., Browne S., Larkin C., O’Callaghan E. Insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv. 2001;52:161-166. https://doi.org/10.1176/appi.ps.52.2.161
61. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med. 1992; 22: 789-797. https://doi.org/10.1017/s0033291700038228
62. Buckley PF., Wirshing DA., Bhushan P., Pierre JM., Resnick SA., Wirshing WC. Lack of insight in schizophrenia: impact on treatment adherence. CNS Drugs. 2007; 21: 129-141. https://doi.org/10.2165/00023210-200721020-00004
63. Kamali M., Kelly BD., Clarke M., Browne S., Gervin M., Kinsella A., Lane A., Larkin C., O’Callaghan E. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry. 2006; 21: 29-33. https://doi.org/10.1016/j.eurpsy.2005.05.015
64. Wittorf A., Jakobi U., Bechdolf A., Müller B., Sartory G., Wagner M., Wiedemann G., Wolwer W., Herrlich J., Buchkremer G., Klingberg S. The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophrenia. Eur Psychiatry. 2009; 24: 259-267. https://doi.org/10.1016/j.eurpsy.2008.12.015
65. San L., Bernardo M., Ingomez A., Pena M. Factors associated with relapse in patients with schizophrenia. International Journal of Psychiatry in Clinical Practice. 2013; 17: 2-9.
66. Olfson M., Ascher-Svanum H., Faries D., Marcus SC. Predicting Psychiatric Hospital Admission Among Adults With Schizophrenia. Psychiatric Services_ps.psychiatryonline.org 2011, 62 (10): 1138-1145. https://doi.org/10.1176/ps.62.10.pss6210_1138
67. Milev P., Ho BC., Arndt S., Andreasen NC.: Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first episode study with 7 year follow up. American Journal of Psychiatry. 162:495-506, 2005. https://doi.org/10.1176/appi.ajp.162.3.495
68. Gorwood P. Factors associated with hospitalization of patients with schizophrenia in four European countries. European Psychiatry. 2011, 26, (4): 224-230. https://doi.org/10.1016/j.eurpsy.2011.02.012
69. Sevy S., Nathanson K., Visweswaraiah H., Amador X. The relationship between insight and symptoms in schizophrenia. Compr Psychiatry. 2004; 45: 16-19. https://doi.org/10.1016/j.comppsych.2003.09.002
70. Smith TE., Hull JW., Israel LM., Willson DF. Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull. 2000; 26:193-200. https://doi.org/10.1093/oxfordjournals.schbul.a033439
71. Mintz AR., Dobson KS., Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res. 2003;61:75-88.
72. Kim C-H., Jayathilake K., Meltzer HY. Hopelessness, neurocognitive function. insight in schizophrenia: relationship to suicidal behavior. Schizophr Res. 2003;60:71-80. https://doi.org/10.1016/s0920-9964(02)00310-9
73. Schwartz RC. Insight and suicidality in schizophrenia: a replication study. J Nerv Ment Dis. 2000;188:235-237.
74. Evren C., Evren B. Characteristics of schizophrenic patients with a history of suicide attempt. Int J Psychiatry Clin Pract. 2004;8:227-234. https://doi.org/10.1080/13651500410005658-1
75. Amador XF., Friedman JH., Kasapis C., Yale SA., Flaum M., Gorman JM. Suicidal behaviour in schizophrenia and its relationship to awareness of illness. Am J Psychiatry. 1996;153:1185-1188.
76. Schwartz-Stav O., Apter A., Zalsman G. Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry. 2006;15:352-359. https://doi.org/10.1007/s00787-006-0541-8
77. McEvoy JP., Johnson J., Perkins D., Libermann JA., Hamer RM., Keefe R., Tohen M., Glick ID., Sharma T.. Insight in first episode psychosis. Psychol Med. 2006;36:1385-1393. https://doi.org/10.1017/s0033291706007793
78. Mutsatsa SH., Joyce EM., Hutton SB., Barnes TR. Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study. Eur Arch Psychiatry Clin Neurosci. 2006;256: 356-363. https://doi.org/10.1007/s00406-006-0645-7
79. Kazadi NJB., Moosa MYH., Jeenah FY., Factors associated with relapse in Schizophrenia. SAJP. 2008, 14(2): 52-62.
80. McEvoy JP., Apperson LJ., Applebaum PS., Ortlip P., Brecosky J., Hammill K., Geller JL., Roth L. Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177:43-47. https://doi.org/10.1097/00005053-198901000-00007
81. Kemp RA., Lambert TJ. Insight in schizophrenia and its relationship to psychopathology. Schizophr Res. 1995;18: 21-28.
82. Carroll A., Fattah S., Clyde Z., Coffey I., Owens DGC., Johnstone EC. Correlates of insight and insight change in schizophrenia. Schizophr Res. 1999;35:247-253. https://doi.org/10.1016/s0920-9964(98)00142-x
83. Smith TE., Hull JW., Santos L. The relationship between symptoms and insight in schizophrenia: a longitudinal perspective. Schizophr Res. 1998;33:63-67.
84. Mohamed S., Rosenheck R., McEvoy J., Swartz M., Stroup S., Lieberman JA. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull. 2009; 35: 336-346. https://doi.org/10.1093/schbul/sbn067
85. Saravanan B., Jacob KS., Johnson S., Prince M., Bhugra D., David AS. Outcome of firstepisode schizophrenia in India: longitudinal study of effect of insight and psychopathology. Br J Psychiatry. 2010;196:454 459. https://doi.org/10.1192/bjp.bp.109.068577
86. Varga M., Magnusson A., Flekkoy K., David AS., Opjordsmoen S. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter? Compr Psychiatry. 2007;48:583-591. https://doi.org/10.1016/j.comppsych.2007.06.003
87. Keshavan MS., Rabinowitz J., DeSmedt G., Harvey PD., Schooler N. Correlates of insight in first episode psychosis. Schizophr Res. 2004;70:187-194.
88. Ritsner MS., Blumenkrantz H. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits. Psychiatry Res. 2007;149:59-69. https://doi.org/10.1016/j.psychres.2006.01.002
89. Shad MU., Keshavan MS., Tamminga CA., Cullum CM., David A. Neurobiological underpinnings of insight deficits in schizophrenia. Int Rev Psychiatry. 2007;19:439-448. https://doi.org/10.1080/09540260701486324
90. Appelbaum PS., Robbins PC., Monahan J. Violence and delusions: data from the MacArthur Violence Risk Assessment Study. Am J Psychiatry. 2000; 157: 566-572. https://doi.org/10.1176/appi.ajp.157.4.566
91. Buckley PF., Noffsinger SG., Smith DA., Hrouda DR., Knoll JL. Treatment of the psychotic patient who is violent. Psychiatr Clin North Am. 2003; 26: 231-272. https://doi.org/10.1016/s0193-953x(02)00029-1
92. Hodgins S.: Mental disorder, intellectual deficiency, and crime: evidence from a birth cohort. Archives of General Psychiatry. 1992,49:476-483. https://doi.org/10.1001/archpsyc.1992.01820060056009
93. Lindqvist P., Allebeck P.: Schizophrenia and crime. British Journal of Psychiatry. 1990, 157:345-350.
94. Wessely SC., Castle D., Douglas AJ., Taylor PJ.: The criminal careers of incident cases of schizophrenia. Psychological Medicine. 1994, 24:483-502. https://doi.org/10.1017/s0033291700027458
95. Beaudoin MN., Hodgins S., Lavoie F.: Homicide, schizophrenia, and substance abuse or dependency. Canadian Journal of Psychiatry. 1993, 38:541-546. https://doi.org/10.1177/070674379303800803
96. Bartels SJ., Drake RE., Wallach MA., Freeman DH.: Characteristic hostility in schizophrenic outpatients. Schizophrenia Bulletin. 1991, 17:163-171. https://doi.org/10.1093/schbul/17.1.163
97. Tardiff K., Koenigsberg HW.: Assaultive behavior among psychiatric outpatients. American Journal of Psychiatry. 1985, 142:960-963. https://doi.org/10.1176/ajp.142.8.960
98. Watson MA., Segal SP., Newhill CE.: Police referral to psychiatric emergency services and its effect on disposition decisions. Hospital and Community Psychiatry. 1993, 44:1085-1090. https://doi.org/10.1176/ps.44.11.1085
99. Kiejna A., Janska-Skomorowska M., Baranowski P.: Medical procedure with aggressive patients: experiences of the psychiatric clinic in Wroclaw. Psychiatria Polska. 1993,27:501-513.
100. Steinert T., Wiebe C., Gebhardt R. Aggressive Behavior Against Self and Others Among First-Admission Patients With Schizophrenia Psychiatric Services. 1999, VOL. 50, No.1. https://doi.org/10.1176/ps.50.1.85
101. Steinert T., Hermer K., Faust V.: Comparison of aggressive and non-aggressive schizophrenic inpatients matched for age and sex. European Journal of Psychiatry.1996, 10:100-107.
102. Greenfield TK., McNiel DE., Binder RL.: Violent behavior and length of psychiatric hospitalization. Hospital and Community Psychiatry. 1989, 40:809-814. https://doi.org/10.1176/ps.40.8.809
103. Arango C., Barba AC., Gonzalez-Salvador T., Ordonez AC. Violence in inpatients with schizophrenia: a prospective study. Schizophr Bull. 1999; 25: 493-503. https://doi.org/10.1093/oxfordjournals.schbul.a033396
104. Buckley PF., Hrouda DR., Freeman L., Noffsinger SG., Resnick PJ., Camlin-Shinger MSSA. Insight and its relationship to violent behavior in patients with schizophrenia. Am J Psychiatry. 2004; 161: 1712-1714. https://doi.org/10.1176/appi.ajp.161.9.1712
105. Strand S., Belfrage H., Fransson G., Levander S. Clinical and risk management factors in risk prediction of mentally disordered offenders-more important than historical data? Legal Criminol Psychol. 1999; 4: 67-76. https://doi.org/10.1348/135532599167798
106. Grevatt A., Thomas-Peter B., Hughes G. Violence, mental disorder and risk assessment: can structured clinical assessments predict the short-term risk of inpatient violence? J Forensic Psychiatry Psychol. 2004; 15: 278-292. https://doi.org/10.1080/1478994032000199095
107. Foley S., Kelly BD., Clarke M., McTigue O., Gervin M., Kamali M., LarkinC, O’Callaghan E., Browne S. Incidence and clinical correlates of aggression and violence at presentation in patients with first episode psychosis. Schizophr Res. 2005; 72: 161-168. https://doi.org/10.1016/j.schres.2004.03.010
108. Cheung P., Schweitzer I., Crowley K., Tuckwell V. Violence in schizophrenia: role of hallucinations and delusions. Schizophr Res. 1997; 26:181-190. https://doi.org/10.1016/s0920-9964(97)00049-2
109. Swartz MS., Swanson JW., Hiday VA., Borum R., Wagner R., Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998; 155: 226-231. https://doi.org/10.1176/ajp.155.2.226
110. Carroll A., Pantelis C., Harvey C. Insight and hopelessness in forensic patients with schizophrenia. Aust N Z J Psychiatry. 2004; 38: 169-173. https://doi.org/10.1080/j.1440-1614.2004.01315.x
111. Arango C., Bombin I., Gonzalez-Salvador T., Garcia-Cabeza I., Bobes J. Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence. Eur Psychiatry. 2006; 21: 34-40. https://doi.org/10.1016/j.eurpsy.2005.07.006
112. Yen CF., Yeh ML., Chen CS., Chung HH. Predictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study. Compr Psychiatry. 2002; 43: 443-447. https://doi.org/10.1053/comp.2002.35901
113. McEvoy JP., Freter S., Everett G., Geller JL., Appelbaum P., Apperson LJ., Roth L. Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis. 1989;177:48-51. https://doi.org/10.1097/00005053-198901000-00008
114. McEvoy JP., Freter S., Merritt M., Apperson LJ. Insight about psychosis among outpatients with schizophrenia. Hosp Community Psychiatry. 1993;44:883-884. https://doi.org/10.1176/ps.44.9.883
115. Drake RJ., Dunn G., Tarrier N., Bentall RP., Haddock G., Lewis SW. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. Journal of Clinical Psychiatry. 2007 68:81-86. https://doi.org/10.4088/jcp.v68n0111
116. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication adherence In schizophrenia: Empirical and clinical findings. Schizophr Bull. 1997; 4: 637-651. https://doi.org/10.1093/schbul/23.4.637
117. Olfson M., Mechanic D., Hansell S., Boyer CA., Walkup J., Weiden PJ. Predicting medication non adherence after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000; 51: 215-222. https://doi.org/10.1176/appi.ps.51.2.216
118. Lincoln TM., Lullmann E., Rief W., Correlates and long-term consequences of poor insight in patients with schizophrenia: a systematic review. Schizophrenia Bulletin. 2007 33:1324-1342. https://doi.org/10.1093/schbul/sbm002
119. Chakraborty K., Basu D. Insight in Schizophrenia – A Comprehensive Update German Journal of Psychiatry. 2010; 13: 17-30.
120. Mohr P., Volavka J. Adherence and long-acting injectable antipsychotics in schizophrenia: an update. Düşünen Adam. The Journal of Psychiatry and Neurological Sciences. 2012;25:285-296. https://doi.org/10.5350/dajpn20122504001
